Status:
COMPLETED
A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma
Lead Sponsor:
Glaukos Corporation
Conditions:
Open-Angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with open-angle glaucoma or ocular hyper...
Detailed Description
The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with open-angle glaucoma or ocular hyper...
Eligibility Criteria
Inclusion
- Diagnosed with open-angle glaucoma (OAG) in the study eye. Pseudoexfoliative and pigmentary glaucoma are also acceptable diagnoses.
- Subject on at least one glaucoma medication
- Able and willing to attend follow up visits for two years post operative
- Able and willing to sign informed consent
Exclusion
- Prior glaucoma procedures (eg trabeculectomy, viscocanalostomy, ALT, SLT, shunt implant, collagen implant, cyclo destructive procedures etc)
- Angle closure glaucoma
- Fellow eye already enrolled
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00323284
Start Date
June 1 2005
End Date
March 1 2010
Last Update
January 12 2018
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Assil Eye Institute
Beverly Hills, California, United States, 90210
2
North Bay Eye Associates Inc
Petaluma, California, United States, 94954
3
Ellison Ambulatory Care Center
Sacramento, California, United States, 95817
4
Harvard Eye Associates
San Clemente, California, United States, 92673